RLAY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.32%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,564,651.81

Relay Therapeutics Insider Trading History Chart

Relay Therapeutics Share Price & Price History

^$2.69

▲ +0.08 (3.07%)

As of 04/17/2025 05:00 PM ET

Days: 30 | 90 | 365

Relay Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/27/2025	Brian Adams	Insider	Sell	298	$2.84	$846.32	405,972
3/27/2025	Thomas Catinazzo	CFO	Sell	4,864	$2.84	$13,813.76	374,567
2/13/2025	Sanjiv Patel	CEO	Sell	75,324	$3.70	$278,698.80	883,089
2/11/2025	Sanjiv Patel	CEO	Sell	140,182	$3.85	$539,700.70	625,948
1/30/2025	Peter Rahmer	Insider	Sell	17,250	$4.42	$76,245.00	402,431
1/30/2025	Thomas Catinazzo	CFO	Sell	20,791	$4.42	$91,896.22	379,431
1/28/2025	Peter Rahmer	Insider	Sell	1,673	$4.63	$7,745.99	307,081
1/28/2025	Thomas Catinazzo	CFO	Sell	36,036	$4.63	$166,846.68	263,190
1/22/2025	Sanjiv Patel	CEO	Sell	125,000	$4.80	$600,000.00	324,548
1/6/2025	Peter Rahmer	Insider	Sell	16,576	$4.45	$73,763.20	308,754
1/2/2025	Peter Rahmer	Insider	Sell	32,156	$4.15	$133,447.40	357,507
12/27/2024	Brian Adams	Insider	Sell	299	$4.38	$1,309.62	321,608
12/27/2024	Thomas Catinazzo	CFO	Sell	4,865	$4.42	$21,503.30	299,226
12/16/2024	Sanjiv Patel	CEO	Sell	100,000	$5.00	$500,000.00	574,548
10/28/2024	Peter Rahmer	Insider	Sell	1,621	$6.06	$9,823.26	390,063
10/28/2024	Thomas Catinazzo	CFO	Sell	6,802	$6.06	$41,220.12	306,391
7/31/2024	Peter Rahmer	Insider	Sell	13,708	$8.19	$112,268.52	391,929
7/29/2024	Peter Rahmer	Insider	Sell	13,523	$8.54	$115,486.42	420,765
7/29/2024	Thomas Catinazzo	CFO	Sell	10,780	$8.56	$92,276.80	319,650
7/26/2024	Sanjiv Patel	CEO	Sell	36,706	$9.07	$332,923.42	766,130
6/27/2024	Donald A. Bergstrom	Insider	Sell	648	$6.26	$4,056.48	526,779
6/27/2024	Thomas Catinazzo	CFO	Sell	9,373	$6.24	$58,487.52	330,430
6/5/2024	Peter Rahmer	Insider	Sell	20,450	$7.06	$144,377.00	432,425
6/3/2024	Peter Rahmer	Insider	Sell	19,864	$6.47	$128,520.08	493,470
4/29/2024	Peter Rahmer	Insider	Sell	1,345	$6.38	$8,581.10	513,334
4/29/2024	Thomas Catinazzo	CFO	Sell	1,695	$6.38	$10,814.10	339,803
3/27/2024	Donald A. Bergstrom	Insider	Sell	765	$7.70	$5,890.50	530,113
3/27/2024	Thomas Catinazzo	CFO	Sell	348	$7.70	$2,679.60	341,498
1/29/2024	Peter Rahmer	Insider	Sell	1,651	$9.64	$15,915.64	514,977
1/29/2024	Thomas Catinazzo	CFO	Sell	2,005	$9.64	$19,328.20	341,846
12/27/2023	Peter Rahmer	Insider	Sell	244	$11.51	$2,808.44	316,628
12/27/2023	Thomas Catinazzo	CFO	Sell	294	$11.51	$3,383.94	143,851
10/30/2023	Peter Rahmer	Insider	Sell	1,354	$6.03	$8,164.62	316,872
10/30/2023	Thomas Catinazzo	CFO	Sell	1,697	$6.03	$10,232.91	144,145
9/27/2023	Donald A. Bergstrom	Insider	Sell	648	$8.38	$5,430.24	238,484
9/27/2023	Thomas Catinazzo	CFO	Sell	294	$8.38	$2,463.72	145,842
7/28/2023	Peter Rahmer	Insider	Sell	1,352	$11.80	$15,953.60	316,808
7/28/2023	Thomas Catinazzo	CFO	Sell	1,693	$11.80	$19,977.40	146,136
6/27/2023	Donald A. Bergstrom	Insider	Sell	647	$12.12	$7,841.64	240,587
6/27/2023	Thomas Catinazzo	CFO	Sell	294	$12.12	$3,563.28	147,829
4/28/2023	Peter Rahmer	Insider	Sell	739	$11.16	$8,247.24	157,504
4/28/2023	Thomas Catinazzo	CFO	Sell	863	$11.16	$9,631.08	149,272
3/27/2023	Peter Rahmer	Insider	Sell	297	$15.36	$4,561.92	158,243
3/27/2023	Thomas Catinazzo	CFO	Sell	347	$15.36	$5,329.92	150,135
2/8/2023	Sanjiv Patel	CEO	Sell	14,000	$20.98	$293,720.00
1/30/2023	Peter Rahmer	Insider	Sell	740	$21.56	$15,954.40	158,540
1/30/2023	Thomas Catinazzo	CFO	Sell	864	$21.56	$18,627.84	150,482
1/18/2023	Sanjiv Patel	CEO	Sell	28,000	$20.87	$584,360.00	254,554
1/12/2023	Brian Adams	Insider	Sell	9,994	$20.00	$199,880.00	51,531
12/27/2022	Donald A. Bergstrom	Insider	Sell	980	$14.49	$14,200.20	85,886
12/27/2022	Thomas Catinazzo	CFO	Sell	445	$14.49	$6,448.05	50,231
11/10/2022	Sanjiv Patel	CEO	Sell	28,000	$20.00	$560,000.00	254,554
11/8/2022	Sanjiv Patel	CEO	Sell	14,000	$20.18	$282,520.00	254,554
11/1/2022	Donald A. Bergstrom	Insider	Sell	8,000	$22.75	$182,000.00	86,866
10/28/2022	Andy Porter	Insider	Sell	448	$21.54	$9,649.92	45,164
10/28/2022	Thomas Catinazzo	CFO	Sell	1,099	$21.54	$23,672.46	50,676
10/12/2022	Sanjiv Patel	CEO	Sell	14,000	$21.18	$296,520.00	254,554
10/3/2022	Donald A. Bergstrom	Insider	Sell	8,000	$22.43	$179,440.00	88,683
9/27/2022	Brian Adams	Insider	Sell	294	$22.73	$6,682.62	62,548
9/27/2022	Thomas Catinazzo	CFO	Sell	443	$22.73	$10,069.39	51,775
9/14/2022	Sanjiv Patel	CEO	Sell	14,000	$23.47	$328,580.00	254,554
9/8/2022	Mark Murcko	Director	Sell	25,000	$29.95	$748,750.00	996,952
9/8/2022	Thomas Catinazzo	CFO	Sell	26,257	$30.00	$787,710.00	52,218
8/24/2022	Donald A. Bergstrom	Insider	Sell	15,000	$25.00	$375,000.00	89,659
8/5/2022	Donald A. Bergstrom	Insider	Sell	8,000	$20.00	$160,000.00	89,659
7/28/2022	Andy Porter	Insider	Sell	452	$21.27	$9,614.04	45,871
7/28/2022	Thomas Catinazzo	CFO	Sell	734	$21.26	$15,604.84	52,218
7/6/2022	Donald A. Bergstrom	Insider	Sell	8,000	$20.00	$160,000.00	91,494
6/27/2022	Andy Porter	Insider	Sell	265	$20.31	$5,382.15	46,323
6/27/2022	Thomas Catinazzo	CFO	Sell	300	$20.31	$6,093.00	52,952
6/24/2022	Donald A. Bergstrom	Insider	Sell	8,000	$20.00	$160,000.00	92,493
5/2/2022	Donald A. Bergstrom	Insider	Sell	13,000	$24.62	$320,060.00	92,493
4/28/2022	Donald A. Bergstrom	Insider	Sell	1,811	$25.57	$46,307.27	92,493
4/28/2022	Thomas Catinazzo	CFO	Sell	725	$25.57	$18,538.25	53,252

See Full Table

SEC Filings (Institutional Ownership Changes) for Relay Therapeutics (NASDAQ:RLAY)

96.98% of Relay Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Relay Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/17/2025	Exchange Traded Concepts LLC	36,293	$95K	0.0%	+75.8%	0.021%
4/16/2025	Wealth Enhancement Advisory Services LLC	15,472	$41K	0.0%	N/A	0.009%
3/18/2025	California State Teachers Retirement System	106,287	$0.44M	0.0%	+28.8%	0.063%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	232,582	$0.96M	0.0%	+4.2%	0.139%
2/17/2025	Voloridge Investment Management LLC	623,339	$2.57M	0.0%	-49.3%	0.372%
2/17/2025	Squarepoint Ops LLC	162,588	$0.67M	0.0%	+535.9%	0.097%
2/17/2025	Twinbeech Capital LP	10,204	$42K	0.0%	N/A	0.006%
2/17/2025	Two Sigma Advisers LP	638,900	$2.63M	0.0%	+4.0%	0.382%
2/17/2025	Two Sigma Investments LP	816,085	$3.36M	0.0%	-19.6%	0.488%
2/17/2025	Tang Capital Management LLC	8,068,058	$33.24M	2.2%	+126.1%	4.820%
2/17/2025	Tema Etfs LLC	64,655	$0.27M	0.1%	N/A	0.039%
2/17/2025	Sherbrooke Park Advisers LLC	28,959	$0.12M	0.0%	-26.7%	0.017%
2/17/2025	Rafferty Asset Management LLC	249,561	$1.03M	0.0%	+38.6%	0.149%
2/17/2025	Raiffeisen Bank International AG	180,000	$0.75M	0.0%	N/A	0.108%
2/17/2025	Point72 Asset Management L.P.	1,592,753	$6.56M	0.0%	+18.0%	0.952%
2/17/2025	ProShare Advisors LLC	42,200	$0.17M	0.0%	+58.0%	0.025%
2/17/2025	MPM Bioimpact LLC	2,268,825	$9.35M	1.3%	+11.6%	1.355%
2/17/2025	Parkman Healthcare Partners LLC	500,548	$2.06M	0.3%	N/A	0.299%
2/17/2025	Man Group plc	173,605	$0.72M	0.0%	N/A	0.104%
2/17/2025	Nuveen Asset Management LLC	653,428	$2.69M	0.0%	+137.5%	0.390%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	330,699	$1.36M	0.1%	+48.9%	0.198%
2/17/2025	Millennium Management LLC	2,568,384	$10.58M	0.0%	+142.4%	1.534%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	78,831	$0.33M	0.0%	+27.5%	0.047%
2/17/2025	Graham Capital Management L.P.	31,569	$0.13M	0.0%	N/A	0.019%
2/17/2025	Ensign Peak Advisors Inc	64,900	$0.27M	0.0%	+17.0%	0.039%
2/17/2025	Deutsche Bank AG	82,460	$0.34M	0.0%	+58.0%	0.049%
2/17/2025	Cubist Systematic Strategies LLC	317,211	$1.31M	0.0%	-11.7%	0.190%
2/17/2025	Casdin Capital LLC	8,948,574	$36.87M	2.5%	-3.3%	5.346%
2/17/2025	Balyasny Asset Management L.P.	692,279	$2.85M	0.0%	N/A	0.414%
2/17/2025	Bank of America Corp DE	457,294	$1.88M	0.0%	-63.5%	0.273%
2/17/2025	BNP Paribas Financial Markets	239,668	$0.99M	0.0%	N/A	0.143%
2/17/2025	Ameriprise Financial Inc.	305,441	$1.26M	0.0%	+10.5%	0.182%
2/17/2025	Algert Global LLC	994,923	$4.10M	0.1%	+93.8%	0.594%
2/14/2025	Boxer Capital Management LLC	536,132	$2.21M	0.2%	N/A	0.320%
2/14/2025	Jane Street Group LLC	75,510	$0.31M	0.0%	-59.3%	0.045%
2/14/2025	PDT Partners LLC	108,599	$0.45M	0.0%	-14.7%	0.065%
2/14/2025	Schonfeld Strategic Advisors LLC	354,500	$1.46M	0.0%	N/A	0.212%
2/14/2025	Northern Trust Corp	1,169,979	$4.82M	0.0%	+24.7%	0.699%
2/14/2025	The Manufacturers Life Insurance Company	218,872	$0.90M	0.0%	+1.5%	0.131%
2/14/2025	Tudor Investment Corp ET AL	86,357	$0.36M	0.0%	+7.0%	0.052%
2/14/2025	Boothbay Fund Management LLC	214,399	$0.88M	0.0%	+2.7%	0.128%
2/14/2025	Susquehanna Fundamental Investments LLC	346,288	$1.43M	0.0%	N/A	0.207%
2/14/2025	Virtus ETF Advisers LLC	14,873	$61K	0.0%	+26.2%	0.009%
2/14/2025	Nebula Research & Development LLC	86,641	$0.36M	0.0%	+118.9%	0.052%
2/14/2025	Voya Investment Management LLC	161,827	$0.67M	0.0%	+392.0%	0.097%
2/14/2025	Adage Capital Partners GP L.L.C.	1,400,000	$5.77M	0.0%	-15.2%	0.836%
2/14/2025	Syon Capital LLC	22,157	$91K	0.0%	N/A	0.013%
2/14/2025	Price T Rowe Associates Inc. MD	3,321,741	$13.69M	0.0%	-37.1%	1.985%
2/14/2025	Hsbc Holdings PLC	111,769	$0.46M	0.0%	+224.7%	0.067%
2/14/2025	Stifel Financial Corp	10,200	$42K	0.0%	N/A	0.006%
2/14/2025	Tower Research Capital LLC TRC	27,128	$0.11M	0.0%	+28.9%	0.016%
2/14/2025	MetLife Investment Management LLC	74,166	$0.31M	0.0%	+28.6%	0.044%
2/14/2025	Dimensional Fund Advisors LP	2,964,997	$12.22M	0.0%	+69.6%	1.771%
2/14/2025	First Trust Advisors LP	89,949	$0.37M	0.0%	N/A	0.054%
2/13/2025	Marshall Wace LLP	27,768	$0.11M	0.0%	-98.0%	0.017%
2/13/2025	Jump Financial LLC	138,226	$0.57M	0.0%	+35.5%	0.083%
2/13/2025	Walleye Capital LLC	927,137	$3.82M	0.0%	-49.1%	0.554%
2/13/2025	XTX Topco Ltd	59,752	$0.25M	0.0%	+26.4%	0.036%
2/13/2025	Barclays PLC	313,202	$1.29M	0.0%	+24.4%	0.187%
2/13/2025	Summit Investment Advisors Inc.	12,730	$52K	0.0%	+41.9%	0.008%
2/13/2025	Raymond James Financial Inc.	189,046	$0.78M	0.0%	N/A	0.113%
2/13/2025	Martingale Asset Management L P	80,371	$0.33M	0.0%	+3.5%	0.048%
2/13/2025	Renaissance Technologies LLC	1,549,190	$6.38M	0.0%	+130.8%	0.926%
2/13/2025	Legal & General Group Plc	124,886	$0.52M	0.0%	-8.2%	0.075%
2/13/2025	Invesco Ltd.	119,417	$0.49M	0.0%	+4.6%	0.071%
2/13/2025	Federated Hermes Inc.	50,100	$0.21M	0.0%	+536.7%	0.030%
2/13/2025	Aristides Capital LLC	43,400	$0.18M	0.0%	N/A	0.026%
2/13/2025	Finepoint Capital LP	2,175,646	$8.96M	0.5%	+33.8%	1.300%
2/13/2025	Russell Investments Group Ltd.	79,804	$0.33M	0.0%	+609.7%	0.048%
2/13/2025	Wells Fargo & Company MN	71,425	$0.29M	0.0%	-45.3%	0.043%
2/12/2025	Trexquant Investment LP	978,137	$4.03M	0.0%	+137.5%	0.584%
2/12/2025	Geode Capital Management LLC	3,030,157	$12.49M	0.0%	+10.9%	1.810%
2/12/2025	Franklin Resources Inc.	58,805	$0.24M	0.0%	-95.8%	0.035%
2/12/2025	Norges Bank	5,781,878	$23.82M	0.0%	N/A	3.454%
2/12/2025	NEOS Investment Management LLC	64,655	$0.27M	0.0%	+10.9%	0.039%
2/12/2025	BIT Capital GmbH	284,508	$1.17M	0.1%	N/A	0.170%
2/12/2025	JPMorgan Chase & Co.	4,978,443	$20.51M	0.0%	-9.8%	2.974%
2/12/2025	TrueMark Investments LLC	55,400	$0.23M	0.1%	-7.7%	0.033%
2/11/2025	EntryPoint Capital LLC	22,325	$92K	0.0%	-15.3%	0.013%
2/11/2025	Prudential Financial Inc.	549,645	$2.27M	0.0%	+45.9%	0.328%
2/11/2025	Corebridge Financial Inc.	60,500	$0.25M	0.0%	+13.8%	0.036%
2/11/2025	Vanguard Group Inc.	15,030,209	$61.92M	0.0%	+3.9%	8.980%
2/11/2025	LPL Financial LLC	24,618	$0.10M	0.0%	-21.1%	0.015%
2/11/2025	KLP Kapitalforvaltning AS	24,700	$0.10M	0.0%	N/A	0.015%
2/11/2025	American Century Companies Inc.	272,166	$1.12M	0.0%	+23.3%	0.163%
2/11/2025	Virtu Financial LLC	15,046	$62K	0.0%	-68.0%	0.009%
2/11/2025	Teacher Retirement System of Texas	33,720	$0.14M	0.0%	+19.5%	0.020%
2/10/2025	Thrivent Financial for Lutherans	166,668	$0.69M	0.0%	+3.9%	0.100%
2/10/2025	Cibc World Markets Corp	11,388	$47K	0.0%	N/A	0.007%
2/7/2025	HighTower Advisors LLC	199,743	$0.82M	0.0%	+28.9%	0.119%
2/7/2025	Intellectus Partners LLC	61,425	$0.25M	0.1%	-9.2%	0.037%
2/7/2025	Mesirow Financial Investment Management Inc.	32,916	$0.14M	0.0%	+126.4%	0.020%
2/7/2025	E Fund Management Co. Ltd.	17,654	$73K	0.0%	+52.8%	0.011%
2/7/2025	Candriam S.C.A.	1,729,199	$7.12M	0.0%	+58.2%	1.033%
2/6/2025	Raymond James Financial Inc.	189,046	$0.78M	0.0%	N/A	0.113%
2/6/2025	Arizona State Retirement System	32,737	$0.14M	0.0%	+30.0%	0.020%
2/6/2025	Victory Capital Management Inc.	15,247	$63K	0.0%	-79.4%	0.009%
2/6/2025	Charles Schwab Investment Management Inc.	1,010,807	$4.17M	0.0%	-2.4%	0.604%
2/6/2025	Steward Partners Investment Advisory LLC	6,500	$27K	0.0%	+160.0%	0.004%
2/4/2025	Los Angeles Capital Management LLC	52,770	$0.22M	0.0%	+65.5%	0.032%

Data available starting January 2016

See Full Table

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhibitor of fibroblast growth factor receptor 2 (FGFR2), which is in a first-in-human clinical trial for patients with advanced or metastatic FGFR2-altered solid tumors; RLY-2608, a lead mutant-PI3Ka inhibitor program that targets phosphoinostide 3 kinase alpha; and Migoprotafib (GDC-1971), an oral, small molecule, potent and selective inhibitor of the protein tyrosine phosphatase SHP2 that binds and stabilizes Src homology region 2 domain-containing phosphatase-2 (SHP2) as a monotherapy in patients with advanced or metastatic solid tumors. In addition, it has collaboration and license agreements with D. E. Shaw Research, LLC to research certain biological targets through the use of D. E. Shaw Research computational modeling capabilities focused on analysis of protein motion to develop and commercialize compounds and products directed to such targets; and Genentech, Inc. for the development and commercialization of GDC-1971. The company was formerly known as Allostery, Inc. and changed its name to Relay Therapeutics, Inc. in December 2015. Relay Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $2.69

$2.54

$2.70

50 Day Range

MA: $3.11

$2.00

$4.16

52 Week Range

Now: $2.69

$1.78

$10.72

Volume

1,629,207 shs

Average Volume

1,967,958 shs

Market Capitalization

$456.01 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.7

Who are the company insiders with the largest holdings of Relay Therapeutics?: Relay Therapeutics' top insider shareholders include:
Sanjiv Patel (CEO)
Donald A Bergstrom (Insider)
Peter Rahmer (Insider)
Brian Adams (Insider)
Thomas Catinazzo (CFO)
Learn More about top insider investors at Relay Therapeutics.
Who are the major institutional investors of Relay Therapeutics?: Relay Therapeutics' top institutional shareholders include:
Exchange Traded Concepts LLC — 0.02%
Wealth Enhancement Advisory Services LLC — 0.01%
Learn More about top institutional investors of Relay Therapeutics stock.
Which institutional investors are buying Relay Therapeutics stock?: Within the previous quarter, RLAY stock was purchased by institutional investors including:
Exchange Traded Concepts LLC
Wealth Enhancement Advisory Services LLC